Due to the current unavailability of brain or cerebrospinal fluid samples from these T2DM patients, it is not feasible to ascertain whether the activation of platelet GSK-3β reflects GSK-3β activation in central nervous system, nor can we provide direct evidence revealing the possible biological relationship between platelet GSK-3β and cognitive impairment. Here, GSK3B is linked to type 2 diabetes mellitus.